Hartalega's new plants to boost production by 15pc

Kuala Lumpur: Hartalega Holdings Bhd's new latex glove manufacturing plant, which is scheduled for completion in the second half of 2019, is expected to boost the company's production capacity by 15 per cent in three year's time. Managing Director Kuan Mun Leong said the company's production capacity would increase to over 44 billion premium latex gloves per year from the current 30 billion per annum.

"As an integral part of our long-term growth plans, we are also accelerating the adoption of Internet of Things (IoT), starting with the new Next Generation Integrated Glove Manufacturing Complex (NGC) Plant 5 which has started production this month," he told reporters after the company's annual general meeting on Friday.

He said the adoption of IoT was not only aimed at improving productivity but also to reduce human error and the dependency on foreign labour, as well as enabling digital monitoring of production lines.

"In the near future, we hope to implement automated glove packaging into boxes which is currently a manual process. We will keep looking at more ways to use IoT tools and big data in our business," said Kuan.

SPONSORED CONTENT

Sabah revenue hits RM6.97 billion: Hajiji says GRS State Government may see full term

Kota Kinabalu: The Sabah Government continued its momentum in managing the economy in line with the commitment and spirit of the Sabah Maju Jaya (SMJ) when it posted record high state revenue of RM6.973 billion last year.

He said the first shipment of its antimicrobial gloves (AMG), the company's newest product, would arrive in Germany for delivery to a medical supplies company.

However, Kuan said there was a delay in the submission of the AMG to the United States (US) Food and Drug Administration (FDA) to obtain export approval into the US market.

"The delay was due to several factors, including test results taking longer than expected, but we hope it will be approved by the second half of 2019," he said.

The managing director said although over 30 per cent of the company's exports was for US consumers, around 60 per cent was for other non-FDA markets including Japan, Korea and other European countries.

Stay up-to-date by following Daily Express’s Telegram channel.

Daily Express Malaysia

"Also, we do not foresee any impact arising from (the current) US-China trade tensions," he added.

Hartelaga's AMG were developed in collaboration with UK-based researchers and provides additional protective coverage to prevent infection during medical examinations, and will be available locally in 2018. – Bernama

Try 1 month for RM 18.00

Try 1 month for RM 18.00

Try 1 month for RM 18.00